These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
490 related articles for article (PubMed ID: 19008009)
1. Fibroblast growth factor receptor 4 regulates proliferation, anti-apoptosis and alpha-fetoprotein secretion during hepatocellular carcinoma progression and represents a potential target for therapeutic intervention. Ho HK; Pok S; Streit S; Ruhe JE; Hart S; Lim KS; Loo HL; Aung MO; Lim SG; Ullrich A J Hepatol; 2009 Jan; 50(1):118-27. PubMed ID: 19008009 [TBL] [Abstract][Full Text] [Related]
2. First Selective Small Molecule Inhibitor of FGFR4 for the Treatment of Hepatocellular Carcinomas with an Activated FGFR4 Signaling Pathway. Hagel M; Miduturu C; Sheets M; Rubin N; Weng W; Stransky N; Bifulco N; Kim JL; Hodous B; Brooijmans N; Shutes A; Winter C; Lengauer C; Kohl NE; Guzi T Cancer Discov; 2015 Apr; 5(4):424-37. PubMed ID: 25776529 [TBL] [Abstract][Full Text] [Related]
3. Targeted inhibition of the FGF19-FGFR4 pathway in hepatocellular carcinoma; translational safety considerations. Mellor HR Liver Int; 2014 Jul; 34(6):e1-9. PubMed ID: 24393342 [TBL] [Abstract][Full Text] [Related]
4. Up-regulation of fibroblast growth factor 19 and its receptor associates with progression from fatty liver to hepatocellular carcinoma. Li Y; Zhang W; Doughtie A; Cui G; Li X; Pandit H; Yang Y; Li S; Martin R Oncotarget; 2016 Aug; 7(32):52329-52339. PubMed ID: 27447573 [TBL] [Abstract][Full Text] [Related]
5. Fibroblast growth factor 19 expression correlates with tumor progression and poorer prognosis of hepatocellular carcinoma. Miura S; Mitsuhashi N; Shimizu H; Kimura F; Yoshidome H; Otsuka M; Kato A; Shida T; Okamura D; Miyazaki M BMC Cancer; 2012 Feb; 12():56. PubMed ID: 22309595 [TBL] [Abstract][Full Text] [Related]
6. Klotho-beta overexpression as a novel target for suppressing proliferation and fibroblast growth factor receptor-4 signaling in hepatocellular carcinoma. Poh W; Wong W; Ong H; Aung MO; Lim SG; Chua BT; Ho HK Mol Cancer; 2012 Mar; 11():14. PubMed ID: 22439738 [TBL] [Abstract][Full Text] [Related]
7. Fibroblast growth factor receptor 4 promotes progression and correlates to poor prognosis in cholangiocarcinoma. Xu YF; Yang XQ; Lu XF; Guo S; Liu Y; Iqbal M; Ning SL; Yang H; Suo N; Chen YX Biochem Biophys Res Commun; 2014 Mar; 446(1):54-60. PubMed ID: 24565842 [TBL] [Abstract][Full Text] [Related]
8. Fibroblast Growth Factor 19-Mediated Up-regulation of SYR-Related High-Mobility Group Box 18 Promotes Hepatocellular Carcinoma Metastasis by Transactivating Fibroblast Growth Factor Receptor 4 and Fms-Related Tyrosine Kinase 4. Chen J; Du F; Dang Y; Li X; Qian M; Feng W; Qiao C; Fan D; Nie Y; Wu K; Xia L Hepatology; 2020 May; 71(5):1712-1731. PubMed ID: 31529503 [TBL] [Abstract][Full Text] [Related]
9. FGF19/FGFR4 signaling contributes to the resistance of hepatocellular carcinoma to sorafenib. Gao L; Wang X; Tang Y; Huang S; Hu CA; Teng Y J Exp Clin Cancer Res; 2017 Jan; 36(1):8. PubMed ID: 28069043 [TBL] [Abstract][Full Text] [Related]
10. FGF19 promotes epithelial-mesenchymal transition in hepatocellular carcinoma cells by modulating the GSK3β/β- catenin signaling cascade via FGFR4 activation. Zhao H; Lv F; Liang G; Huang X; Wu G; Zhang W; Yu L; Shi L; Teng Y Oncotarget; 2016 Mar; 7(12):13575-86. PubMed ID: 26498355 [TBL] [Abstract][Full Text] [Related]
11. Brivanib alaninate, a dual inhibitor of vascular endothelial growth factor receptor and fibroblast growth factor receptor tyrosine kinases, induces growth inhibition in mouse models of human hepatocellular carcinoma. Huynh H; Ngo VC; Fargnoli J; Ayers M; Soo KC; Koong HN; Thng CH; Ong HS; Chung A; Chow P; Pollock P; Byron S; Tran E Clin Cancer Res; 2008 Oct; 14(19):6146-53. PubMed ID: 18829493 [TBL] [Abstract][Full Text] [Related]
12. Fibroblast growth factor receptor 4 regulates tumor invasion by coupling fibroblast growth factor signaling to extracellular matrix degradation. Sugiyama N; Varjosalo M; Meller P; Lohi J; Hyytiäinen M; Kilpinen S; Kallioniemi O; Ingvarsen S; Engelholm LH; Taipale J; Alitalo K; Keski-Oja J; Lehti K Cancer Res; 2010 Oct; 70(20):7851-61. PubMed ID: 20876804 [TBL] [Abstract][Full Text] [Related]
13. Up-regulation of FGF15/19 signaling promotes hepatocellular carcinoma in the background of fatty liver. Cui G; Martin RC; Jin H; Liu X; Pandit H; Zhao H; Cai L; Zhang P; Li W; Li Y J Exp Clin Cancer Res; 2018 Jul; 37(1):136. PubMed ID: 29973237 [TBL] [Abstract][Full Text] [Related]
14. The fibroblast growth factor receptor-4 Arg388 allele is associated with gastric cancer progression. Ye Y; Shi Y; Zhou Y; Du C; Wang C; Zhan H; Zheng B; Cao X; Sun MH; Fu H Ann Surg Oncol; 2010 Dec; 17(12):3354-61. PubMed ID: 20844967 [TBL] [Abstract][Full Text] [Related]
15. Implications of FGF19 on sorafenib-mediated nitric oxide production in hepatocellular carcinoma cells - a short report. Gao L; Shay C; Lv F; Wang X; Teng Y Cell Oncol (Dordr); 2018 Feb; 41(1):85-91. PubMed ID: 28983785 [TBL] [Abstract][Full Text] [Related]
16. Association between fibroblast growth factor receptor 4 polymorphisms and risk of hepatocellular carcinoma. Yang Y; Zhou Y; Lu M; An Y; Li R; Chen Y; Lu DR; Jin L; Zhou WP; Qian J; Wang HY Mol Carcinog; 2012 Jul; 51(7):515-21. PubMed ID: 21656577 [TBL] [Abstract][Full Text] [Related]
17. Fibroblast growth factor receptor 4 regulates proliferation and antiapoptosis during gastric cancer progression. Ye YW; Zhou Y; Yuan L; Wang CM; Du CY; Zhou XY; Zheng BQ; Cao X; Sun MH; Fu H; Shi YQ Cancer; 2011 Dec; 117(23):5304-13. PubMed ID: 21567388 [TBL] [Abstract][Full Text] [Related]
18. FGFR4 Arg388 allele is associated with resistance to adjuvant therapy in primary breast cancer. Thussbas C; Nahrig J; Streit S; Bange J; Kriner M; Kates R; Ulm K; Kiechle M; Hoefler H; Ullrich A; Harbeck N J Clin Oncol; 2006 Aug; 24(23):3747-55. PubMed ID: 16822847 [TBL] [Abstract][Full Text] [Related]
19. Development of a Potent and Specific FGFR4 Inhibitor for the Treatment of Hepatocellular Carcinoma. Rezende Miranda R; Fu Y; Chen X; Perino J; Cao P; Carpten J; Chen Y; Zhang C J Med Chem; 2020 Oct; 63(20):11484-11497. PubMed ID: 33030342 [TBL] [Abstract][Full Text] [Related]
20. Overexpression of fibroblast growth factor receptor 4 in high-grade pancreatic intraepithelial neoplasia and pancreatic ductal adenocarcinoma. Motoda N; Matsuda Y; Onda M; Ishiwata T; Uchida E; Naito Z Int J Oncol; 2011 Jan; 38(1):133-43. PubMed ID: 21109934 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]